Google partners with the American Medical Association to promote data sharing
CNBC has revealed that technology giant Google is set to partner with the American Medical Association to find new ways to share data within the AMA's Healthcare Interoperability and Innovation Challenge.
The challenge will see start ups look at new methods to support data sharing between patients and medical providers, particularly for those with long-term health conditions. This could incorporate the importation of patient data from a mobile app or wearable, or the extraction of data from a clinical interface, which is then sent back to a mobile application of health wearable, the Clinical Innovation & Technology has stated.
"The winning entries will demonstrate how the applicant uses patient-generated health data in meaningful ways to have maximum impact on improving physician workflow, improving clinical outcomes, and reducing cost in the health-care system," the AMA has said.
The three most successful ideas which are submitted will gain a combined $50,000 in credits for Google Cloud.
- How accessible 3D printing can improve quality of life
- The telehealth revolution is underway, but some hurdles remain
- Digitally enhancing the patient experience
“The challenge we’re announcing today is an extension of the AMA’s work and will explore possible uses of mobile health technology to provide patients and physicians with a rich stream of medical data that is important for improving care and long-term wellness,” explained AMA President David O. Barbe, MD, MHA.
“The Integrated Health Model Initiative seeks to evolve available health data to depict a complete picture of a patient’s journey, from wellness to illness to treatment and beyond, that allows health care delivery to fully focus on patient function, state, outcomes and goals,” the AMA adds.
“This includes a long-term focus on identifying, developing and reviewing new data elements, as well as associated relationships and rules using a clinical review process.”
“One area of particular interest is the use of mobile technology to transform health care to improve the patient-physician relationship,” it adds. “This Challenge focuses on exploring possibilities in this space.”
NeuTigers: edge AI in healthcare
What is edge AI?
Edge AI is essentially a combination of edge computing and artificial intelligence. Algorithms are processed locally - directly on a mobile device or server - rather than in the cloud. This reduces cost, computing power and energy requirements. There are also claims that edge AI is so fast it is possible to reach near real-time analytics.
Edge AI devices include smart speakers, smart phones, laptops, robots, self-driven cars, drones, and surveillance cameras that use video analytics.
Who is NeuTigers?
NeuTigers is a spin-off company from Princeton University, formed in 2018 to apply edge AI and machine learning to solve challenges in healthcare, energy, productivity, and security.
With offices in Princeton, NJ, the company is based at one of the top AI accelerator programs of FutureLabs in New York, and has also established a subsidiary in Nice, France.
How is NeuTigers applying edge AI to healthcare?
The NeuTigers AI Technology Stack uses deep neural networks that mimic how the human brain perceives and interprets the world. The company has developed the StarDeepTM Smart Health Platform for health monitoring and biomedical imaging, to improve the accuracy and speed of diagnosing diseases.
NeuTigers say the platform has the potential to monitor and screen for thousands of conditions, when used in combination with medical devices and smart sensors already deployed in healthcare settings.
Are there any real world examples?
In January NeuTigers launched CovidDeep, a tool that predicts COVID-19 with more than 90% accuracy, using physiological data from a wristband along with blood pressure and blood oxygen readings. It then analyses the data and gives a prediction within two minutes.
This week NeuTigers announced a new study to detect the early signs of complications with sickle cell anaemia. Conducted at a hospital in Paris, the research will begin by looking at changes to skin response, heart beat, sleep and temperature to predict an acute episode of sickle cell anaemia, and how this impacts on the patients’ disease conditions and quality of life.
The second phase of the project is to expand with prospective studies across different sites in EU, Africa and the US to explore the models' accuracy and clinical effectiveness.
Adel Laoui, CEO and founder of NeuTigers, says: “The best way to deal with a crisis is to avoid it happening in the first place. We are now entering a new era where medical early warning systems have become a reality.
“We are excited at the possibility of deploying a technology that can save lives of patients dealing with sickle cell anaemia. The potential of the StarDeep platform to dramatically improve patient outcomes while slashing some of the highest costs of healthcare makes it one of the most exciting developments in preventative personal medicine.”